Long-term safety of sorafenib in advanced renal cell carcinoma: follow-up of patients from phase III TARGET

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Thomas E HutsonSorafenib TARGET Clinical Trial Group

Abstract

The phase III Treatment Approaches in Renal cancer Global Evaluation Trial (TARGET) indicated that sorafenib is effective and well tolerated in advanced renal cell carcinoma patients. However, few data have been published on the safety of long-term sorafenib treatment. A retrospective subgroup analysis was performed to evaluate the efficacy and safety of sorafenib in patients in TARGET who received treatment for >1 year. The present subgroup analysis (based on the September 2006 database with updated safety analysis) evaluated the efficacy and safety of sorafenib in all patients in the sorafenib arm of TARGET who were treated for >1 year. The assessments included the overall survival, progression-free survival (PFS), disease control rate (DCR), and safety. The patients remained on therapy post-progression at the discretion of the investigator. In TARGET, 169 patients received treatment with sorafenib for >1 year. The median PFS of patients in this subpopulation was 10.9 months from the date of randomisation, with a DCR of 92%. The most commonly reported treatment-related adverse events of any grade were diarrhoea (74%), rash/desquamation (51%), hand-foot skin reaction (49%), alopecia (39%), and fatigue (38%). Adverse events wer...Continue Reading

References

Oct 5, 2001·Lancet·G H MickischUNKNOWN European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group
Jan 12, 2007·The New England Journal of Medicine·Bernard EscudierUNKNOWN TARGET Study Group
May 12, 2007·European Urology·Paul C M S Verhagen
Oct 9, 2008·Journal of the National Cancer Institute·Tim EisenUNKNOWN TARGET Study Group
Jan 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernard EscudierRonald M Bukowski
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernard EscudierRonald M Bukowski
Oct 3, 2009·The Lancet Oncology·Brian I Rini, Michael B Atkins
Dec 17, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas E HutsonRobert A Figlin
Jan 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cora N SternbergRobert E Hawkins

❮ Previous
Next ❯

Citations

Nov 28, 2012·Cancer Chemotherapy and Pharmacology·Wei-Xiang QiZan Shen
Nov 1, 2011·Investigational New Drugs·Jennifer ArrondeauFrançois Goldwasser
Sep 10, 2013·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Nielka P van ErpJan den Hartigh
Jan 10, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G DranitsarisM E Lacouture
Jan 12, 2012·Journal of the National Cancer Institute·Tim EisenBernard Escudier
Sep 26, 2012·Onkologie·MinYuen TeoDerek G Power
Jul 4, 2012·The Oncologist·Pascaline Boudou-RouquetteFrançois Goldwasser
Dec 18, 2013·Expert Opinion on Pharmacotherapy·Hideyuki Akaza, Tomofusa Fukuyama
Nov 18, 2011·Expert Opinion on Investigational Drugs·A A CrawshawH S Young
Aug 22, 2015·Expert Opinion on Drug Metabolism & Toxicology·Laure-Anne TeuwenLuc Dirix
Jul 15, 2015·International Journal of Clinical Oncology·Kenji OmaeKazunari Tanabe
Jul 9, 2013·Critical Reviews in Oncology/hematology·Mario MandalàVincenzo De Giorgi
Jun 7, 2011·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Kim EdmondsAlexander Molassiotis
Feb 16, 2012·BJU International·Masahiro NozawaHirotsugu Uemura
Mar 1, 2014·Seminars in Oncology·Marcia S BroseStacey M Stein
May 10, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Atsunari KawashimaUNKNOWN Osaka Renal Cell Carcinoma Clinical Study Collaboration
May 5, 2016·Expert Opinion on Drug Safety·Lisa DerosaBernard Escudier
Sep 29, 2011·Critical Reviews in Oncology/hematology·Sergio BracardaUNKNOWN Sorafenib Working Group
Nov 16, 2017·Japanese Journal of Clinical Oncology·Hiroki IshiharaKazunari Tanabe
Nov 3, 2010·Journal of Gastroenterology and Hepatology·Brian I CarrKathleen Gondek
Jun 29, 2011·Expert Review of Anticancer Therapy·Bernard Escudier
Sep 26, 2019·Postgraduate Medical Journal·Yashdeep Singh Pathania
Oct 3, 2018·International Journal of Urology : Official Journal of the Japanese Urological Association·Norihiko Tsuchiya
Mar 6, 2017·Journal of Cancer Research and Clinical Oncology·Marjut NiinivirtaGustav J Ullenhag
Aug 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G DranitsarisM E Lacouture

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

The New England Journal of Medicine
Bernard EscudierTARGET Study Group
The New England Journal of Medicine
Giancarlo Spinzi, Silvia Paggi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Mark J RatainPeter J O'Dwyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Bernard EscudierRonald Bukowski
© 2021 Meta ULC. All rights reserved